iSpecimen shares surged nearly 43% in after-hours trading following the launch of its AI-powered Inventory Agent.
iSpecimen Inc. (NASDAQ:ISPC ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Phil Carlson - IR, KCSA Strategic Communications Tracy Curley - CEO and CFO Leslie Hoyt - VP, Operations Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Operator Good morning everyone and welcome to the iSpecimen Second Quarter 2024 Earnings Conference Call. At this time, participants are in a listen-only mode.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Matthew Stead Sachetta, LLC | 0.05 | $5.32 | $0.12 | -$5.2 | -97.74% |
| Professional Services Industry | Industrials Sector | Katharyn Field CEO | NASDAQ (CM) Exchange | 45032V306 CUSIP |
| US Country | 7 Employees | - Last Dividend | 28 Apr 2026 Last Split | 17 Jun 2021 IPO Date |
iSpecimen Inc. is a pioneering force in the realm of life sciences, supplying a crucial bridge between life science researchers and a wide spectrum of human biospecimens necessary for their groundbreaking research endeavors. Since its founding in 2009 with its headquarters based in Lexington, Massachusetts, the company has distinguished itself by leveraging advanced cloud-based technology. This innovative approach facilitates a seamless connection between scientists in need of specific human biofluids, tissues, and living cells, and a comprehensive network of healthcare providers globally. The extensive network encompasses hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. iSpecimen Inc.'s mission is to streamline the traditionally cumbersome process of sourcing biospecimens, thereby accelerating the pace of scientific discovery and medical advancements.
iSpecimen Marketplace:
This proprietary online platform stands at the core of iSpecimen Inc.'s offerings, engineered to revolutionize how medical researchers access the subjects, samples, and data essential for their studies. By facilitating a direct connection between researchers and a vast repository of available specimens across a multitude of healthcare and research institutions, the iSpecimen Marketplace significantly cuts down on the time and resources typically required to identify and acquire necessary biospecimens. The inclusivity of the platform spans across various types of biospecimens, encompassing human biofluids, tissues, living cells, among others. Catering primarily to biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions, the marketplace leverages cutting-edge technology to meet the complex demands of modern-day research.